
Google announces applications for startup accelerators in India
on Tuesday announced that applications are now open for the
Google for Startups Accelerator
: AI First India 2025 program.
According to the official statement by Google, this initiative is aimed at supporting India's growing AI ecosystem by helping startups in the Seed to Series A stages. Startups focused on Agentic AI and Multimodal AI are especially encouraged to apply. The deadline for applications is June 30.
It said "As a part of our continued efforts to support this vibrant ecosystem and contribute to the broader goals of the IndiaAI Mission, with the support of
MeitY
Startup Hub, we are excited to open the applications for the Google for Startups Accelerator: AI First program in India".
India's tech scene is expanding quickly, driven by skilled professionals and a strong economy. Artificial Intelligence is being adopted rapidly, with the government making it a priority through efforts like the IndiaAI Mission.
Google also noted that according to projections, India's Generative AI market is expected to exceed USD 17 billion by 2030. AI is also set to play a key role in helping the country achieve its USD 1 trillion digital economy target by 2028.
Through this accelerator program, Google stated that the selected startups will get access to top-tier mentorship from Google teams including DeepMind, Cloud, Android, Play, Ads, and others. Startups will also receive one-on-one support based on their goals and progress, guided by dedicated startup success managers.
Participants will have access to free Cloud TPUs, Cloud credits (if eligible), and the latest AI tools and models from Google. They will also get hands-on support in integrating advanced AI models such as Gemini, Gemma, Imagen, and Veo to overcome technical challenges.
Last year, the tech giant noted that the accelerator program had a major impact. Participating startups raised over USD 61 million in funding and gained access to the Google Cloud Marketplace, helping them reach new markets and improve their products.
It said "Last year's Google for Startups Accelerator: AI First India program significantly impacted participating startups, resulting in over USD 61M in cumulative funding, Google Cloud Mrketplace integration for expanded market access, and notable product improvements".
Google hopes to support and empower the next wave of AI-driven startups through this year's program.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Economic Times
16 minutes ago
- Economic Times
Regulatory gray area makes investing in LVMH, BP tough For Indian retail
The world's largest sovereign fund, Norges Bank, credited European stocks for the gains this year in a rare episode in recent years. But Indian retail investors, who on paper can invest lakhs of USD overseas, are missing the European bus as an unreasoned regulatory cap holds back mutual funds from launching schemes that could benefit from what appears to be a continental renaissance. The MSCI Europe Index has soared 22% since January, easily


Hindustan Times
16 minutes ago
- Hindustan Times
Man accused of selling fake meds denied bail
A Delhi court on Monday denied anticipatory bail to a man accused of supplying fake Ozempic medicines to several foreign companies, observing that such instances threaten the reputation of India's pharmaceutical industry and endanger public health. (Getty Images/iStockphoto) Ozempic is used to cure Type-2 Diabetes and is an anti-obesity medication used for long-term weight management. The order was passed by additional sessions judge Saurabh Partap Singh Laler of Patiala House Court. The court was deciding on an anticipatory bail plea moved by Vicky Ramancha, who has been accused of criminal conspiracy and cheating a foreign firm by supplying them counterfeit pharmaceutical drugs, specifically Ozempic. A case was lodged against Ramancha by the Delhi Police Economic Offences Wing (EOW). The court said, 'The discretionary remedy of anticipatory bail cannot be granted in circumstances where allegations involve grave offences against public health and safety, international ramifications threaten India's pharmaceutical industry reputation…grant of bail would undermine public confidence in criminal justice system.' The prosecution claimed that the accused was part of a trans-national fraud operation that purportedly caused financial losses exceeding USD 18.8 million to the complainant company. The police further claimed that investigation revealed a systematic pattern of criminal misconduct wherein false representation was created by the accused of having legitimate pharmaceutical supply chains and government connections in India. Police said that false certificates were notarised by Patiala House Courts itself to create a false impression and build trust for larger transactions. To be sure, the case also attracted the attention of US federal authorities, wherein the complainant company received subpoenas (notice to appear in court or produce evidence) from the US Department of Justice regarding potential violations of federal criminal laws, including importation and misbranded drugs. Advocate Yagyesh Kumar, appearing for the accused, argued that the case did not fall within the territorial jurisdiction of the court as the transaction took place outside the country and a commercial arbitration case was already ongoing at London Court of International Arbitration (LCIA). He further added that the fake medicines were due to genuine business difficulties rather than with a criminal intent.


India Today
31 minutes ago
- India Today
Trump threatens lawsuit against Fed chair Powell over costly renovations
US President Donald Trump has intensified his criticism of Federal Reserve Chair Jerome Powell, saying he is considering allowing a 'major lawsuit' over Powell's handling of costly renovations at the Fed's Washington, DC, a Truth Social post on Tuesday, Trump accused Powell of overseeing 'grossly incompetent' management of the project, which he claimed has soared to USD 3 billion from what should have been a USD 50 million fix-up. advertisementWhite House press secretary Karoline Leavitt confirmed the president is considering legal action but offered no further details. So far, the Fed has not issued any response over the matter. The renovations, involving two historic buildings, were originally budgeted at USD 1.9 billion but are now projected to cost USD 2.4 billion, according to Fed documents. The central bank attributes the overruns to higher labor and materials costs, asbestos abatement, and other unforeseen has repeatedly pressured Powell to slash interest rates, arguing that lower borrowing costs would save the US billions. The Fed, which raised rates in 2022 and cut them several times in 2024, has so far held them steady in 2025 despite Trump's demands. Powell has previously pushed back, including during a recent meeting with Trump at the construction site.A Supreme Court ruling earlier this year reaffirmed that the Fed chair cannot be removed by the president over policy disagreements, highlighting the central bank's independence.- EndsTune InMust Watch